Clean Science and Technology (CLEAN)₹695.95+1.76%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Clean Science and Technology reported sales of ₹299 Cr, up 22.1% from Sep 2025, and net profit of ₹55.95 Cr, up 1.8% year on year. For the year to Mar 2026, sales were ₹956 Cr and net profit ₹230 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 195 | 228 | 224 | 238 | 241 | 264 | 243 | 245 | 220 | 249 | 268 | 299 |
| Expenses | 108 | 133 | 129 | 148 | 142 | 159 | 143 | 158 | 147 | 153 | 172 | 208 |
| Operating Profit | 87.26 | 95.19 | 95.20 | 90.17 | 98.20 | 105 | 100 | 87.22 | 72.22 | 96.28 | 96.25 | 92.26 |
| OPM % | 44.0% | 42.0% | 42.0% | 38.0% | 40.9% | 39.9% | 40.9% | 36.0% | 33.0% | 38.0% | 35.9% | 31.0% |
| Other Income | 7.99 | 14.01 | 10.01 | 11.01 | 4.99 | 11.99 | 13.01 | 6.99 | 9.99 | 3.01 | 21.99 | 5.99 |
| Interest | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 |
| Depreciation | 11.04 | 13.05 | 16.06 | 18.05 | 18.06 | 17.05 | 19.05 | 19.07 | 19.07 | 21.07 | 21.05 | 21.06 |
| Profit before tax | 83.20 | 95.14 | 89.24 | 83.14 | 85.22 | 100 | 95.17 | 75.20 | 63.14 | 78.19 | 98.23 | 74.11 |
| Tax % | 25.0% | 26.0% | 26.0% | 29.0% | 23.0% | 26.0% | 26.0% | 26.0% | 27.0% | 25.0% | 25.0% | 25.0% |
| Net Profit | 62.94 | 69.94 | 65.91 | 58.92 | 65.94 | 73.95 | 69.89 | 54.98 | 45.97 | 57.95 | 72.88 | 55.95 |
| EPS (Rs) | 5.88 | 6.60 | 6.19 | 5.52 | 6.17 | 6.95 | 6.58 | 5.21 | 4.31 | 5.47 | 6.89 | 5.23 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 393 | 419 | 512 | 685 | 936 | 791 | 966 | 956 | 1,036 |
| Expenses | 167 | 258 | 235 | 254 | 386 | 534 | 460 | 580 | 602 | 681 |
| Operating Profit | 74.20 | 137 | 186 | 261 | 301 | 404 | 333 | 389 | 357 | 357 |
| OPM % | 30.9% | 34.9% | 44.0% | 50.9% | 43.9% | 42.9% | 42.0% | 39.9% | 37.0% | 34.5% |
| Other Income | 4.99 | 11.01 | 10.99 | 24.98 | 29.97 | 30.01 | 41.01 | 38.99 | 32.01 | 40.98 |
| Interest | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 1.01 | 1.01 | 1.01 | 1.99 |
| Depreciation | 8.02 | 11.03 | 14.03 | 17.06 | 25.08 | 36.14 | 46.16 | 69.22 | 78.28 | 82.25 |
| Profit before tax | 70.14 | 137 | 182 | 268 | 306 | 397 | 326 | 358 | 311 | 314 |
| Tax % | 30.0% | 28.0% | 23.0% | 26.0% | 25.0% | 25.0% | 25.0% | 26.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.99 | 0.00 | 0.00 | — |
| Net Profit | 48.95 | 97.95 | 140 | 198 | 228 | 295 | 244 | 264 | 230 | 233 |
| EPS (Rs) | 4.32 | 8.62 | 13.15 | 18.65 | 21.46 | 27.72 | 22.95 | 24.82 | 21.56 | 21.90 |
| Dividend payout % | 12.1% | 15.1% | 2.0% | 134.0% | 15.1% | 18.1% | 22.1% | 24.1% | 28.0% | — |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.01 | 1.01 | 1.01 | 11.02 | 11.02 | 11.01 | 11.01 | 11.01 | 11.01 |
| Reserves | 186 | 271 | 342 | 530 | 759 | 1,000 | 1,195 | 1,409 | 1,575 |
| Borrowings | 1.01 | 2.99 | 3.01 | 0.00 | 0.00 | 2.01 | 2.01 | 1.99 | 1.99 |
| Other Liabilities | 48.23 | 53.26 | 84.90 | 120 | 157 | 140 | 192 | 181 | 185 |
| Total Liabilities | 237 | 328 | 431 | 661 | 926 | 1,153 | 1,398 | 1,603 | 1,773 |
| Fixed Assets | 102 | 127 | 166 | 187 | 297 | 461 | 638 | 717 | 762 |
| CWIP | 1.99 | 3.99 | 2.99 | 54.90 | 43.85 | 19.95 | 56.85 | 29.93 | 118 |
| Investments | 17.95 | 74.78 | 133 | 232 | 191 | 352 | 338 | 380 | 404 |
| Other Assets | 114 | 121 | 129 | 188 | 395 | 319 | 366 | 476 | 488 |
| Inventories | 28.99 | 36.97 | 34.98 | 53.01 | 88.04 | 109 | 124 | 149 | 154 |
| Trade receivables | 40.14 | 60.26 | 70.21 | 74.27 | 155 | 147 | 165 | 204 | 207 |
| Cash & equivalents | 29.93 | 8.98 | 8.97 | 15.96 | 74.85 | 11.98 | 10.97 | 19.94 | 27.94 |
| Total Assets | 237 | 328 | 431 | 661 | 926 | 1,153 | 1,398 | 1,603 | 1,773 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 44.87 | 84.72 | 160 | 192 | 127 | 278 | 235 | 213 | 274 |
| Cash from investing activity | −17.02 | −94.10 | −105 | −187 | −79.02 | −270 | −185 | −152 | −202 |
| Cash from financing activity | −5.02 | −11.04 | −55.25 | −6.02 | 0.00 | −55.21 | −53.20 | −53.22 | −64.26 |
| Net cash flow | 22.97 | −19.96 | 0.00 | 0.00 | 48.89 | −44.93 | −1.99 | 8.99 | 7.98 |
| Capex | 32.08 | 39.09 | 50.10 | 84.16 | 140 | 183 | 232 | 142 | 201 |
| Free cash flow | 12.97 | 45.90 | 110 | 109 | −11.97 | 95.83 | 9.97 | 71.91 | 73.84 |
| CFO / OP % | 90.9% | 88.0% | 109.0% | 100.0% | 65.0% | 92.9% | 93.9% | 79.9% | 102.9% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 59 | 54 | 60 | 52 | 81 | 56 | 75 | 76 | 78 |
| Inventory days | 93 | 79 | 98 | 156 | 143 | 122 | 163 | 156 | 157 |
| Days payable | 85 | 48 | 101 | 180 | 166 | 90 | 139 | 103 | 118 |
| Cash conversion cycle | 70 | 88 | 59 | 30 | 60 | 90 | 100 | 130 | 119 |
| Working capital days | 59 | 61 | 32 | 31 | 89 | 67 | 85 | 105 | 109 |
| ROCE % | — | 58.9% | 59.0% | 61.0% | 46.9% | 43.9% | 28.9% | 26.9% | 21.0% |
For the Sep 2026 quarter, Clean Science and Technology reported sales of ₹299 Cr, up 22.1% year on year and net profit of ₹55.95 Cr, up 1.8% year on year. The operating margin was 31.0%.
Clean Science and Technology's sales for the year to Mar 2026 were ₹956 Cr; over the last twelve months they were ₹1,036 Cr.
Net profit for the year to Mar 2026 was ₹230 Cr, and ₹233 Cr over the last twelve months. Earnings per share over the same trailing period were ₹21.90.
Clean Science and Technology reported borrowings of ₹1.99 Cr at Mar 2026, against cash and equivalents of ₹27.94 Cr.
Cash from operations was ₹274 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹73.84 Cr.